EXAGET

Exaget was set up to smartly mobilise applications and services used by consumers and businesses today and creating new ones that will be needed in the future. They launched their first service at the end of 2012 – technology that delivers customized and targeted audio advertisements and other content to listeners based on their profile. They provide the service to broadcasters and advertisers to leverage the benefits that smartphone technology can deliver to their business.
EXAGET
Industry:
Ad Network Advertising Mobile Personalization
Founded:
2012-01-01
Address:
Helsinki, Southern Finland, Finland
Country:
Finland
Website Url:
http://www.exaget.com
Total Employee:
1+
Status:
Active
Contact:
358 5048 62963
Total Funding:
1.33 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics WordPress Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving Apache
Similar Organizations
Adcash
Adcash, an ad-serving platform, provides targeted solutions and tools for publishers and advertisers to create online campaigns.
Founder
Investors List
Gorilla Ventures Oy
Gorilla Ventures Oy investment in Seed Round - Exaget
Finnvera Venture Capital
Finnvera Venture Capital investment in Seed Round - Exaget
Angels Den
Angels Den investment in Seed Round - Exaget
Official Site Inspections
http://www.exaget.com
- Host name: 172.67.133.122
- IP address: 172.67.133.122
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Exaget"
Exagen Inc. - Autoimmune Disease Testing Lab - Rheumatology Lab
At Exagen, our mission is clear to offer solutions to address the medical needs of our community. On behalf of all of us at Exagen, we’re committed to being your partner and persevering …See details»
Exagen - Crunchbase Company Profile & Funding
Exagen’s goal is to enable providers to improve care for patients through the differential diagnosis, prognosis and monitoring of complex autoimmune and …See details»
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 …
Dec 31, 2024 About Exagen. Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with …See details»
Exagen - H.I.G. Capital Portfolio Company
Exagen, Inc., is a commercial stage company focused on developing and marketing products to community rheumatologists. Exagen’s flagship diagnostic product, AVISE CTD, is a …See details»
Working At Exagen: Company Overview and Culture - Zippia
May 18, 2020 We calculated Exagen's diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Exagen's workforce. Exagen …See details»
Exagen - businessabc.net
Feb 25, 2025 Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United …See details»
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises …
Mar 31, 2024 Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of …See details»
Exagen Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 Exagen has 1 employees at their 1 location and $55.64 m in annual revenue in FY 2024. See insights on Exagen including office locations, competitors, revenue, financials, …See details»
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024
Dec 31, 2024 Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of …See details»
Exagen Inc. - Wikidata
Nov 18, 2024 clinical laboratory company. This page was last edited on 18 November 2024, at 19:34. All structured data from the main, Property, Lexeme, and EntitySchema namespaces is …See details»
Autoimmune Disease Testing Lab - Life Sciences Company
About Exagen Inc. Exagen is dedicated to transforming the care continuum for patients suffering from debilitating chronic autoimmune diseases. Our portfolio of innovative products enable …See details»
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 …
Mar 11, 2025 Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of …See details»
Exagen - Contacts, Employees, Board Members, Advisors
Organization. Exagen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 5. ... Exagen has 7 board …See details»
Exagen Group - Crunchbase Company Profile & Funding
Exagen Group may be growing as it has recently received approval for a 20MW energy storage facility, which indicates an expansion of its operations in the renewable energy sector. The …See details»
Exagen Inc. Reports Strong Second Quarter 2023 Results
Jun 30, 2023 SAN DIEGO, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the …See details»
Exagen Inc. Reports Strong Fourth Quarter and Full-Year
Mar 11, 2025 Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of …See details»
Exagens - Crunchbase Company Profile & Funding
Located in Montreal Canada, a world-leader in Artificial Intelligence & machine learning, the exagens team of industry veterans, economists, psychologists and technologists has cracked …See details»
Tyler O’Malley Of Exagen - Medium
Mar 9, 2025 An example for me at Exagen was the leadership change in our CEO that took place in October of 2022. That was a real test for many people because the business was at a …See details»
Exagen Inc. Achieves Key Milestone with 1,000,000th Patient
Dec 12, 2024 Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD ... “Aiding in the care of our 1,000,000 th patient is a huge milestone for our organization …See details»
EXAGEN INC. CODE OF CONDUCT AND ETHICS
US-DOCS\109667753.2 EXAGEN INC. CODE OF CONDUCT AND ETHICS In accordance with the requirements of the Securities and Exchange Commission (the “SEC”) and the Nasdaq …See details»